Schedule 13G ownership disclosure

AEGLEA BIOTHERAPEUTICS INC

Security class unavailable · CUSIP: 00773J103

Event date: 2023-06-26

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,469,927
Percent of class
9.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-24-000060
Form type
SC 13G
Filer
Logos Global Management LP
CIK
CIK 1792126
Filed
Jan 22, 2024
Reporting period
Jun 26, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub